Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma

Autor: Song, Yuqin, Kim, Won-Seog *, Yoon, Dok-Hyun *, Yang, Haiyan *, Cao, Junning, Ji, Dongmei *, Koh, Youngil, Jing, Hongmei, Eom, Hyeon-Seok *, Kwak, Jae-Yong, Lee, Won-Sik, Lee, Jong-Seok *, Shin, Ho-Jin *, Jin, Jie, Wang, Mei *, Li, Jingrun *, Zhu, Jun
Zdroj: In Blood 15 November 2022 140 Supplement 1:6545-6546
Databáze: ScienceDirect